Literature DB >> 8078303

Experimental fetal and transplacental Neospora infection in the nonhuman primate.

B C Barr1, P A Conrad, K W Sverlow, A F Tarantal, A G Hendrickx.   

Abstract

BACKGROUND: Neospora is a newly recognized Toxoplasma-like protozoan that causes spontaneous abortion and/or neonatal disease in a wide range of animals. The purpose of this study was to determine the susceptibility of primates to Neospora infection. EXPERIMENTAL
DESIGN: In experiment 1, two rhesus macaque fetuses were inoculated in utero at gestational day 65 with 1 x 10(6) culture-derived Neospora tachyzoites. A control fetus was given uninfected vehicle. The fetuses were removed by hysterotomy between 13 and 22 days postinoculation. In experiment 2, two pregnant macaques were inoculated intramuscularly and intravenously on gestational day 43 with a total of 1.6 x 10(7) culture-derived tachyzoites. A pregnant control macaque was given uninfected vehicle. The fetuses were removed by hysterotomy between 67 to 70 days postinoculation. Fetal tissues were collected for in vitro parasite isolation, histopathology, and Neospora immunohistochemistry. Fetal blood was examined for Neospora-specific antibody titers using an indirect fluorescent antibody test.
RESULTS: Neospora infections were confirmed in all fetuses that received tachyzoites either directly or via transplacental infection. In experiment 1, infected fetuses had reduced amniotic fluid volumes, marked protozoal amnionitis and dermatitis, and a mild multifocal encephalitis. Infected fetuses from experiment 2 had a chronic multifocal necrotizing nonsuppurative meningoencephalitis with microcavitation, that was confined to the cerebrum, and a mild multifocal necrotizing amnionitis. In both experiments, Neospora tachyzoites were detected in association with lesions in fetal tissues by immunohistochemistry, and the parasites were reisolated in vitro. IgG Neospora antibody titers were detected in blood from all infected fetuses, whereas Neospora-specific IgM and IgA titers were found in one and three fetuses, respectively.
CONCLUSIONS: Results indicate that nonhuman primates are susceptible to transplacental Neospora infection. The fetal lesions after transplacental infection are similar to those induced by transplacental Toxoplasma infections in primates.

Entities:  

Mesh:

Year:  1994        PMID: 8078303

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Antibody reaction of human anti-Toxoplasma gondii positive and negative sera with Neospora caninum antigens.

Authors:  H W Nam; S W Kang; W Y Choi
Journal:  Korean J Parasitol       Date:  1998-12       Impact factor: 1.341

2.  Identification of bovine Neospora parasites by PCR amplification and specific small-subunit rRNA sequence probe hybridization.

Authors:  M S Ho; B C Barr; A E Marsh; M L Anderson; J D Rowe; A F Tarantal; A G Hendrickx; K Sverlow; J P Dubey; P A Conrad
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Central nervous system rendez-vous--canine progressive posterior paresis.

Authors:  P B Little
Journal:  Can Vet J       Date:  1996-01       Impact factor: 1.008

4.  Detection of Neospora from tissues of experimentally infected rhesus macaques by PCR and specific DNA probe hybridization.

Authors:  M S Ho; B C Barr; A F Tarantal; L T Lai; A G Hendrickx; A E Marsh; K W Sverlow; A E Packham; P A Conrad
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Sensitive and specific identification of Neospora caninum infection of cattle based on detection of serum antibodies to recombinant Ncp29.

Authors:  Daniel K Howe; Keliang Tang; Patricia A Conrad; Karen Sverlow; J P Dubey; L David Sibley
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

6.  Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders.

Authors:  Janaína Lobato; Deise A O Silva; Tiago W P Mineo; Jodi D H F Amaral; Gesmar R Silva Segundo; Julia M Costa-Cruz; Marcelo S Ferreira; Aércio S Borges; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2006-01

Review 7.  Review of Neospora caninum and neosporosis in animals.

Authors:  J P Dubey; John Dubey
Journal:  Korean J Parasitol       Date:  2003-03       Impact factor: 1.341

8.  Serological evidence of human infection with the protozoan Neospora caninum.

Authors:  J Tranas; R A Heinzen; L M Weiss; M M McAllister
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 9.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

10.  Lack of serologic evidence of Neospora caninum in humans, England.

Authors:  Catherine M McCann; Andrew J Vyse; Roland L Salmon; Daniel Thomas; Diana J L Williams; John W McGarry; Richard Pebody; Alexander J Trees
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.